All News

January 12, 2018 was a busy day for health care headlines. See what you recall from 3 news stories on 1/12/18 (and a bonus story from 1/10/18).

Can a physician's age affect treatment outcome? It did in this study of hospitalized elderly patients.

This 43-year-old man has known alcohol addiction but has never had post-withdrawal leg weakness. What tests would you order to Dx cause? 

For PCPs, now poised to play a bigger role in screening and care for patients with HCV, we highlight 10 forces reshaping the HCV landscape.

Methadone and buprenorphine are underutilized as treatment for opioid addiction. Is one safer? More effective? More convenient? Take the quiz.

Our app reviewer toplines the Pixel 2 features that busy PCPs need most. Brand allegiance aside, aren't new smartphone features always worth a look? 

Newest news on coffee, from BMJ: "...more likely to benefit health than to harm it..." High vs low intake reduces risk of diabetes and  Alzheimer disease. Plus, more. 

Physical exam, including vitals, is normal although patient is tremulous. Blood sent for labs, so look for clues in the ECG. 

Here: a quick look at newly approved agents for primary care that will soon be coming your way.

A predictive model that replaces cigarette smoking with vaping projects nearly 21 million fewer life-years lost.

Hallucinations and rambling speech came on suddenly and are getting worse. Review history and ECG. What's your diagnosis?

Click through this slide-show primer on 5 apps that support mental health assessment and treatment in the primary care setting.

The CDC's annual report on STD rates in the United States is in, and the news about chlamydia, gonorrhea, and syphilis is not good.

6 patients who presented with lumps, bumps, and spots. Your diagnoses?

This month’s Special Report post-test allows you to gauge how much you have learned about current approaches to treating migraine headache.

"Bigorexia" is the male version of anorexia nervosa. Could you spot it in your practice? More about being a man with a "woman's disorder" in these slides.

Monoclonal antibodies that inhibit calcitonin gene-related peptide could revolutionize preventive migraine therapy. Here's what you need to know.

HRT, tattoos, insurers exacerbating the opioid epidemic, prolonged sitting, plus a new COPD drug: here's a recap of 5 of the week's key news reports.